美国肺癌切除术质量与结局的机构层面差异
该回顾性研究分析美国国家癌症数据库中2004至2015年接受NSCLC切除术的169,775例患者,评估六项可避免的低质量标志物对机构间长期生存差异的影响。NCI指定癌症中心五年总生存率为66%,社区项目为52%;依次排除低质量标志物后,机构间生存差异缩小但未消除,手术切除与术后护理质量差异可解释11%至26%的机构间生存差异。
要点
- 不同机构NSCLC切除术后5年总生存率从52%至66%不等,NCI指定中心最高。
- 六项可避免低质量标志物可解释11%至26%的机构间生存差异。
- 社区项目受质量改进影响最大,但机构间生存差异未完全消除。
核心结论
- 针对六项可识别的低质量标志物可缩小但未消除机构间NSCLC生存差异。
- 手术切除与术后护理质量差异可解释11%至26%的机构间生存差异。
- 社区项目受质量改进影响最大,残余因素仍需进一步表征以消除差异。
研究设计与样本
- 回顾性分析美国国家癌症数据库中2004至2015年接受NSCLC切除术的患者。
- 共纳入169,775例患者,机构分为社区、综合社区、整合网络、学术和NCI指定癌症项目五类。
- 评估六项可避免低质量标志物并计算调整OR,通过序贯排除法计算调整风险比以量化总生存影响。
主要发现
- 7%、46%、10%、24%和12%的患者分别在社区、综合社区、整合网络、学术和NCI指定癌症项目接受手术。
- 五类机构5年总生存率分别为52%、56%、58%、60%和66%。
- 以NCI指定中心为参照,序贯排除前社区、综合社区、整合网络和学术项目的调整风险比分别为1.47(95%CI 1.41-1.53)、1.29(95%CI 1.25-1.33)、1.18(95%CI 1.14-1.23)和1.20(95%CI 1.16-1.24)。
- 序贯排除后上述调整风险比分别变为1.35(95%CI 1.28-1.42)、1.22(95%CI 1.17-1.26)、1.16(95%CI 1.11-1.22)和1.17(95%CI 1.12-1.21),与NCI指定项目比较均P < .001。
- 手术切除与术后护理质量差异可解释11%至26%的机构间生存差异。
关键数值与推荐
- 六项可避免低质量标志物包括:不完全切除、淋巴结未检查、非解剖性切除、非循证辅助化疗、非循证辅助放疗和术后60天死亡。
临床怎么用
- 呼吸科及胸外科可参照六项低质量标志物对NSCLC切除术进行机构层面质量监测与改进。
- 社区项目应优先针对可避免的低质量标志物开展质量改进以缩小生存差异。
局限性
- 残余因素驱动持续存在的机构间长期NSCLC生存差异,需进一步表征以消除差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Institutional-level disparities in non-small cell lung cancer (NSCLC) survival may be driven by reversible differences in care-delivery processes. We quantified the impact of differences in readily identifiable quality metrics on long-term survival disparities in resected NSCLC. RESEARCH QUESTION: How do reversible differences in oncologic quality of care contribute to institutional-level disparities in early-stage NSCLC survival? STUDY DESIGN AND METHODS: We retrospectively analyzed patients in the National Cancer Data Base who underwent NSCLC resection from 2004 through 2015 within institutions categorized as Community, Comprehensive Community, Integrated Network, Academic, and National Cancer Institute (NCI)-Designated Cancer Programs. We estimated percentages and adjusted ORs for six potentially avoidable poor-quality markers: incomplete resection, nonexamination of lymph nodes, nonanatomic resection, non-evidence-based use of adjuvant chemotherapy, non-evidence-based use of adjuvant radiation therapy, and 60-day postoperative mortality. By sequentially eliminating patients with poor-quality markers and calculating adjusted hazard ratios, we quantified their overall survival impact. RESULTS: Of 169,775 patients, 7%, 46%, 10%, 24%, and 12% underwent surgery at Community, Comprehensive Community, Integrated Network, Academic, and NCI-Designated Cancer Programs, with 5-year overall survival rates of 52%, 56%, 58%, 60% and 66%, respectively. After the sequential elimination process, using NCI-Designated Cancer Centers as a reference, the adjusted hazard ratio for 5-year overall survival changed from 1.47 (95% CI, 1.41-1.53), 1.29 (95% CI, 1.25-1.33), 1.18 (95% CI, 1.14-1.23), and 1.20 (95% CI, 1.16-1.24) for Community, Comprehensive Community, Integrated Networks, and Academic Cancer Programs to 1.35 (95% CI, 1.28-1.42), 1.22 (95% CI, 1.17-1.26), 1.16 (95% CI, 1.11-1.22), and 1.17 (95% CI, 1.12-1.21), respectively (P < .001 for all comparisons with NCI-designated programs). Differences in quality of surgical resection and postoperative care accounted for 11% to 26% of the interinstitutional survival disparities. INTERPRETATION: Targeting six readily identified poor-quality markers narrowed, but did not eliminate, institutional survival disparities. The greatest impact was in community programs. Residual factors driving persistent institution-level long-term NSCLC survival disparities must be characterized to eliminate them.
引用
- Osarogiagbon RU, Sineshaw HM, Lin CC, et al. Institutional-Level Differences in Quality and Outcomes of Lung Cancer Resections in the United States. Chest. 2020. PMID: 33197400. doi:10.1016/j.chest.2020.10.075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。